ArticleACR open rheumatology2026

Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.

Laure Gossec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.